It’s just E*Trade and the other platforms putting their “best price” software to use for retail in a stock that has hardly any real volume. Just volleying back and fourth. Meanwhile look at rival IBRX making deals everywhere. Even with Feuerstein against them. Nice website too.

Beyond three decimals you have no ability to make that call. That’s up to mm’s.

The additional how much?

>>I just couldn't justify the additional 10 cents.

Meaningless move on market cap with little volume. Real conviction in this stock with such a low market cap and shares outstanding should mean share price moves of $1 at a clip until it hits minimum $200M. Take a look at IBRX. This could be a simple sympathy play we’re seeing and has nothing to do with Vera’s activities. He’s doing a terrible job getting the word out.

Forget the cross Shareholders are delivered constant golden showers.

>> Stocks trade to five decimals (subpennies) primarily for penny stocks and low-priced securities to capture tiny price movements (sub-pennys), increasing liquidity and precision, especially when the minimum tick (one cent) isn't small enough to reflect true market dynamics, though it adds complexity and isn't standard for most major stocks. This finer granularity helps reduce the bid-ask spread, benefiting small investors, but specialized brokers and platforms are often needed.

The very best case scenario is MHRA is waiting on more data to eventually green light L for a specific tiny subset of patients that will somehow get the NICE nod. But it’ll mean little to investors. Advent is the key to ever getting ROI so you should all focus on that.

Yes and no. If the markets thought there was anything at all to L there should’ve been a sympathy play.

You’d think NWBO stock would be riding IBRX’s wave but no. 🤷‍♀️

But patients wish it were so.

>>The idea he was somehow trying to steal the tech and/or the company is just spin started by LP.

Need to distinguish between poor retail shareholders and wealthy financiers and shorts.

>>Many don't like her and many do like her. Not an opinion.

So you’re saying the big pump and dump hasn’t happened yet?

>>And the longer term could present bad optics for investors because often when investors are making an investment in the company, they're expecting to have a liquidity event within less than 10 years. And if you have a term that's more than that, you're signaling that the investor could be waiting a long time to get liquidity for their shares.

https://www.lowenstein.com/news-insights/podcasts-listing/expiring-stock-options-what-can-the-employer-do

Pages and pages of pure silliness this holiday weekend.

https://www.facebook.com/VintageGeekCentral/videos/monty-pythons-flying-circus-ministry-of-silly-walks/1339531490808955/

Thought you said surgeons only saw an abscess? How was GBM confirmed?

Just look at the news on a simple copper supplement.

“War chest”. 🤣🤣🤣. Is that what they call it?

Hey Jerry, without the blocker is there any other way for LP and LG to have been able to extend the warrants/options?

Retail are lucky for the few centurions at the gate. But it’s a thankless job here.

I’ve always thought she delayed the MAA submittal until the MHRA broke loose from EMA, probably because they wouldn’t allow them to file either?

Maybe you haven’t noticed but technology is running by LP and DCVAX as she spends years doing who knows what. If L were any threat to business BioNTech would’ve taken tiny broke NWBO out already.

>>Dr Maria Koufali, Life Sciences Industry Director at NIHR, said:

"The UK’s integrated research system is built to help life science companies move faster from promising science to robust evidence. By connecting Autolus with NHS sites, specialist facilities, and experienced investigators, NIHR support is helping bring innovative cell therapies closer to patients.”

https://www.nihr.ac.uk/news/nice-recommends-next-generation-immunotherapy-blood-cancer

PPHM Fargo all over again! Anything to weave a story so the candy store remains open.

>>Poison pill or corporate sabotage?

We “accidentally” did not oversee our fabricator make our Eden unit bigger instead of smaller, boy did that slow down our closed system manufacturing start date estimation.

And nanotechnology will have matured.

>>By the time NWBO has commercial Eden production, the manufacturing plant could be fusion powered.

>>Conclusions

Although direct evidence linking Crohn's disease or syphilis to improved GBM outcomes is currently limited, emerging research suggests that these conditions may modulate the immune system in ways that could theoretically influence GBM progression. Specifically, the chronic immune activation associated with both Crohn's disease and syphilis may enhance immune surveillance, potentially increasing the detection and elimination of tumor cells. Additionally, these immune alterations could modulate the tumor microenvironment through changes in microglial activation and cytokine expression, creating conditions that are less favorable for tumor growth. However, it is important to emphasize that these hypotheses remain speculative, and further research is necessary to clarify any potential causal relationships.

https://www.cureus.com/articles/428058-extremely-long-term-glioblastoma-survival-ten-years-a-possible-role-of-immune-modulation-from-pre-existing-diseases#!/

https://rarecancernews.com/news/new-cell-therapy-glioblastoma-doubles-progression-free-survival-trial/

https://www.curetoday.com/view/given-months-to-live-shes-now-a-five-year-glioblastoma-survivor

Nobody knows. I think the fake announcement probably put Boyton in the basement.

https://www.onclive.com/view/braincancer_vaccine_covfeature

He/She/Them will go down in history with the first to announce “Approval in Switzerland!”.🤣🤷🏻‍♂️🤷‍♀️

Guess on the defunct business they were looking at?

That’s wrong. On another note, what’s LP paying in Delaware franchise tax for billions of authorized shares?

https://www.wolterskluwer.com/en/expert-insights/delaware-incorporation-why-the-number-of-authorized-shares-matters#:~:text=ComplianceNovember%2006%2C%202025,with%20what%20your%20corporation%20needs.

We’ve had this conversation. If we find out in the 10k that the blocker is gone, I’ll believe your version. And if it’s still there, I’ll go with my version that it’s a demand by the financiers. Or is it possible she set up the blocker just to get an extension on the options/warrants? I hadn’t considered that.

You dope, I was looking for a change in the 10k language (what I thought you meant) that doesn’t exist.

Forget it, Flip’s lost in yet another AI dimension. It would be interesting to know if a release on the blocker would require an immediate material event filing or only if they sold?
.

Here we go again. The 10k says notice to the company not the shareholders.

>>They would have known when they put that voluntary blockage in the 10k that the 60 day notice to shareholders

Now that LP has more authorized she can submit a letter to herself changing the 60 day window so it doesn't matter, as per Ex. UNLESS a financier is stopping her from doing so.  But even then there's a thirty day window between the 60 days and the 90 day q filings.  

Exactly.

IBRX on a tear. Feuerstein doesn’t trust the CEO Soon-Shiong. Definitely doesn’t trust Powers. Interesting comparison between the Invisible Lady and Scientist-Salesman of the Year.

That’s a good point. But then why even have a blocker? To keep LG from selling and digging into the authorized? Or because the financiers didn’t want her or LG selling into their game and if she tried to change the “agreement” they’d be privy to it?

Numbnuts. This STILL stands, so there’s no confusion.

10k:
>>Ms. Powers and Mr. Goldman are subject to a voluntary blocking agreement under which they cannot exercise any options, warrants or other derivative securities unless they provide the Company at least 61 days’ advance notice.